Aclaris Therapeutics, Inc.

GOLDMAN SACHS GROUP INC ACRS

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

632,502

Value ($000)

1,904

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	1,904	0.0%	632,502	12/31/2025
2025 Q3	11/14/2025	1,816	0.0%	956,051	9/30/2025
2025 Q2	8/14/2025	222	0.0%	156,572	6/30/2025
2025 Q1	6/27/2025	851	0.0%	555,953	3/31/2025
2024 Q4	2/11/2025	1,063	0.0%	428,587	12/31/2024
2024 Q3	11/14/2024	347	0.0%	301,556	9/30/2024
2024 Q2	8/13/2024	1,008	0.0%	916,620	6/30/2024
2024 Q1	5/15/2024	181	0.0%	145,812	3/31/2024
2023 Q4	5/14/2024	547	0.0%	520,880	12/31/2023
2023 Q3	5/15/2024	1,869	0.0%	272,821	9/30/2023
2023 Q2	5/14/2024	4,042	0.0%	389,786	6/30/2023
2023 Q1	5/14/2024	2,400	0.0%	296,642	3/31/2023
2022 Q4	5/14/2024	5,470	0.0%	347,298	12/31/2022
2022 Q3	5/14/2024	6,646	0.0%	422,247	9/30/2022
2022 Q2	5/14/2024	5,694	0.0%	407,889	6/30/2022
2022 Q1	5/16/2022	4,456	0.0%	258,459	3/31/2022
2021 Q4	2/17/2022	3,217	0.0%	221,192	12/31/2021
2021 Q3	1/20/2022	7,939	0.0%	441,094	9/30/2021
2021 Q2	8/13/2021	5,711	0.0%	325,275	6/30/2021
2021 Q1	5/17/2021	3,039	0.0%	120,582	3/31/2021
2020 Q4	2/12/2021	170	0.0%	26,307	12/31/2020
2020 Q3	11/13/2020	68	0.0%	26,307	9/30/2020
2020 Q2	8/12/2020	57	0.0%	35,112	6/30/2020
2020 Q1	5/15/2020	25	0.0%	24,086	3/31/2020
2019 Q4	2/14/2020	86	0.0%	45,709	12/31/2019